| Particulars |
|
|
|
| Company Name
| Zydus Lifesciences Ltd
| Year End
| 202303
|
| Full Year |
| Equity (₹ Cr.) |
100.62 |
B.V. (₹) |
145.10 |
| Sales(₹ Cr.) |
8,731.60 |
NP (₹ Cr.) |
1,621.61 |
| NP Var (%) |
48.00 |
Div% |
600.00 |
| CPS(₹) |
21.00 |
EPS (₹) |
16.10 |
| Traded Value(₹ Lakhs) |
1,796.42 |
52 Week High |
1,057.00 |
| 52 Week Low |
483.00 |
Price BSE |
1,052.00 |
| Price NSE |
1,051.00 |
Market Capital (₹ Cr.) |
105,845.75 |
| P/C Ratio |
50.20 |
P/E Ratio |
65.30 |
| Price Vs.BV |
7.25 |
|
| Latest Quarter |
| Year End |
202403 |
Sales (₹ Cr.) |
3,172.60 |
| NP(₹ Cr.) |
1,411.72 |
NP Var % |
117.00 |
| Trailing Twelve Months |
| Year End |
202312 |
Sales |
7,682.70 |
| OPM |
29.20 |
NP |
1,226.50 |
| NP Var (%) |
109.11 |
EPS |
26.71 |
| PE |
39.38 |
|
|